Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of Response to DMARDs in Rheumatoid Arthritis
NCT03414502Phase 3Recruiting
- Sponsor
- University of Nebraska
- Start
- Dec 2007
- Primary completion
- Mar 2028
- Modality
- Antibody Fragments, Polymer-based Nanoparticles, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate, abatacept, adalimumab, azathioprine, baricitinib in rheumatoid arthritis (RA), sponsored by University of Nebraska. Started Dec 2007; status: recruiting.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03414502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03414502.